May 12, 2026 08:00AM
Mar 31, 2026 08:00AM
Mar 31, 2026 08:00AM
Mar 25, 2026 08:05AM
Mar 25, 2026 08:05AM
Feb 5, 2026 08:05AM
Feb 5, 2026 08:05AM IMUNON SHARPENS FOCUS ON ITS PROMISING PIVOTAL PHASE 3 OVARIAN CANCER STUDY
Nov 13, 2025 07:45AM
Nov 10, 2025 07:31AM
Nov 10, 2025 07:30AM
Nov 10, 2025 07:30AM
Nov 10, 2025 07:30AM
Oct 30, 2025 08:00AM
Oct 30, 2025 08:00AM IMUNON to Present Phase 3 OVATION 3 Study of IMNN-001 in Advanced Ovarian Cancer at IGCS 2025 Annual Global Meeting
Oct 23, 2025 10:01AM
Oct 23, 2025 10:01AM
Oct 14, 2025 08:20AM
Oct 14, 2025 08:20AM
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM
Jun 17, 2025 08:05AM IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™
May 23, 2025 08:05AM
May 15, 2025 08:06AM
May 15, 2025 08:05AM
May 12, 2025 08:00AM
Mar 24, 2025 08:05AM
Mar 24, 2025 08:00AM
Feb 28, 2025 08:09AM Imunon (IMNN) PT Raised to $14 at H.C. Wainwright
Feb 27, 2025 08:05AM
Nov 26, 2024 07:06AM
Nov 7, 2024 08:05AM
Oct 31, 2024 08:30AM
Oct 30, 2024 09:05AM
Sep 9, 2024 04:06PM
Sep 9, 2024 08:30AM IMUNON’s Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management
Aug 14, 2024 08:00AM
May 13, 2024 08:00AM
Apr 18, 2024 08:31AM
Apr 18, 2024 08:30AM
Apr 11, 2024 08:00AM
Apr 11, 2024 08:00AM
Mar 28, 2024 08:00AM IMUNON Reports 2023 Financial Results and Provides Business Update
Mar 13, 2024 08:00AM
Mar 13, 2024 08:00AM
Feb 29, 2024 08:31AM
Feb 29, 2024 08:30AM
Feb 22, 2024 08:00AM
Nov 14, 2023 08:00AM
Oct 23, 2023 08:30AM IMUNON’s Chief Science Officer to Present at the 3rd International Vaccines Congress
Aug 10, 2023 08:00AM

323,590 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All